Respiratory syncytial virus laboratory surveillance and hospitalization trends in south Texas

被引:4
作者
Fergie, Jaime [1 ]
Purcell, Kevin
机构
[1] Driscoll Childrens Hosp, Dept Pediat, Corpus Christi, TX 78411 USA
[2] Texas A&M Univ, Hlth Sci Ctr, Coll Med, College Stn, TX USA
[3] CHRISTUS Santa Rosa Hlth Care, San Antonio, TX USA
[4] Univ Texas, Hlth Sci Ctr, Sch Med, Dept Pediat, San Antonio, TX USA
关键词
respiratory syncytial virus; broncbiolitis; seasonality; RSV hospitalization;
D O I
10.1097/INF.0b013e318157daae
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surveillance of seasonal variations in respiratory syncytial virus (RSV) outbreaks is an important component in clinical decision-making. A retrospective analysis of I I years of laboratory-based RSV surveillance and 7 years of hospitalization data was carried out to better define the onset and duration of the RSV season in South Texas, as well as to evaluate the clinical impact and timing of RSV outbreaks on the number of infants hospitalized with RSV infection. All but one of the seasons examined lasted longer than the national and southern seasons reported by the Centers for Disease Control and Prevention. In addition, most seasons started earlier and ended later than the national and regional seasons. Considerable parallels were noted between RSV hospital admission frequency and number of RSV-positive tests, as determined by rapid antigen detection or viral culture. Taken together, these results reflect the clinical utility of RSV surveillance data and highlight the impact of RSV on infant hospitalization.
引用
收藏
页码:S51 / S54
页数:4
相关论文
共 7 条
[1]  
HUDAK M, 2002, J PERINATOL, V22, P619
[2]   Substantial variability in community respiratory syncytial virus season timing [J].
Mullins, JA ;
Lamonte, AC ;
Bresee, JS ;
Anderson, LJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (10) :857-862
[3]  
Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531
[4]   Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: Results from the Palivizumab Outcomes Registry [J].
Parnes, C ;
Habersang, R ;
Nicholes, P ;
Chawla, V ;
Kelly, T ;
Fishbein, J ;
McRae, P ;
Goessler, M ;
Gatti, A ;
Calcagno, JA ;
Eki, C ;
Harris, KA ;
Joyave, J ;
McFarland, K ;
Protter, P ;
Sullivan, M ;
Stanford, A ;
Lovett, N ;
Ortiz, M ;
Rojas, S ;
Cyrus, S ;
Cyrus, J ;
Cohen, S ;
Buchin, D ;
Riordan, L ;
Zuniga, M ;
Shah, R ;
Minard, C ;
Quintin, A ;
Douglas, G ;
van Houten, J ;
Freutner, S ;
Chartrand, S ;
Nowatzke, P ;
Romero, J ;
Rhodes, T ;
Benoit, M ;
Walter, E ;
Walker, L ;
DeBonnett, L ;
Free, T ;
Martin, S ;
Shank, K ;
Guedes, B ;
Atkinson, LA ;
Halpin, GJ ;
Rouse, K ;
Hand, I ;
Geiss, D ;
Marshall, JR .
PEDIATRIC PULMONOLOGY, 2003, 35 (06) :484-489
[5]   Driscoll Children's Hospital respiratory syncytial virus database - Risk factors, treatment and hospital course in 3308 infants and young children, 1997 to 2002 [J].
Purcell, K ;
Fergie, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (05) :418-423
[6]  
PURCELL K, 2005, INF DIS SOC AM 40 AN
[7]  
NATL RESP ENTERIC VI